DDDeniz Demirtaş

Deniz Demirtaş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deniz Demirtaş has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fractalkine Profile in Different Regions of the Brain from the Early Postnatal Period to Adolescence

    by Ozlem Aycan, Deniz Demirtaş, Burak Gülcen, Hasan Çalışkan

    In the present study, fractalkine levels were investigated in different brain regions and serum from the early postnatal period to adolescence. Thirty Wistar albino male rats aged 15, 30, and 41 days were used (n = 10 per group). After sacrifice, the prefrontal cortex, hypothalamus, thalamus, striatum, hippocampus, temporal lobe, and serum were analyzed by ELISA. A cumulative increase was observed in the thalamus, temporal lobe, and serum toward adolescence. In contrast, a cumulative decrease was observed in the hippocampus and striatum toward adolescence. The highest fractalkine levels were measured in the prefrontal cortex of 15-day-old rats, in the thalamus of 30-day-old rats, and in the thalamus and cerebellum of 41-day-old rats. Traumas that may occur during early developmental stages can negatively affect fractalkine production and neuroimmunity.

  • Open Access

    Volumetric Evaluation of Substantia Nigra in Major Depressive Disorder Using Atlas-Based Method

    by Ömür Karaca, Deniz Demirtaş, Emrah Özcan, Merve Şahin Can, Aybars Kökce

    Aim: The substantia nigra pars compacta (SNc), a vital part of the brain that produces dopamine, is being closely studied due to its potential role in the monoamine hypothesis, which aims to explain the causes of Major Depressive Disorder (MDD). Dopamine, a chemical messenger in the brain, is linked to the monoamine hypothesis, suggesting that imbalances in these chemicals may contribute to MDD. This study aimed to calculate volumetric changes in the substantia nigra (SN), using brain magnetic resonance imaging (MRI) in individuals diagnosed with MDD. Material and Method: Sixty-six participants, comprising 33 individuals diagnosed with MDD (mean age=44.30±13.98 years) and 33 healthy individuals (mean age=46.27±14.94 years), were recruited from the university hospital psychiatry outpatient clinic. In the MDD group, there were 15 male participants (45%) and 18 female participants (55%). The healthy control group consisted of 28 males (84.8%) and 5 females (16.2%). Potential confounding factors, such as underlying chronic diseases, were ruled out by the clinician through a thorough examination of the patient's medical history, ensuring the study outcomes were not influenced. Three-dimensional brain MRI scans were conducted using a 1.5 Tesla MRI scanner. Volumes of the SN and midbrain were automatically computed using MRIStudio, an atlas-based image analysis program. Results: Statistically significant higher volumes were observed in the right SN in the MDD group compared to controls (0.146±0.045 cm³ vs. 0.122±0.035 cm³, p=0.02, p